Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Dev Biol ; 421(2): 161-170, 2017 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-27919666

RESUMEN

Hensen's node is the "organizer" of the avian and mammalian early embryo. It has many functions, including neural induction and patterning of the ectoderm and mesoderm. Some of the signals responsible for these activities are known but these do not explain the full complexity of organizer activity. Here we undertake a functional screen to discover new secreted factors expressed by the node at this time of development. Using a Signal Sequence Trap in yeast, we identify several candidates. Here we focus on Calreticulin. We show that in addition to its known functions in intracellular Calcium regulation and protein folding, Calreticulin is secreted, it can bind to BMP4 and act as a BMP antagonist in vivo and in vitro. Calreticulin is not sufficient to account for all organizer functions but may contribute to the complexity of its activity.


Asunto(s)
Proteínas Morfogenéticas Óseas/antagonistas & inhibidores , Calreticulina/metabolismo , Inducción Embrionaria , Tejido Nervioso/embriología , Tejido Nervioso/metabolismo , Organizadores Embrionarios/metabolismo , Animales , Proteínas Morfogenéticas Óseas/metabolismo , Calnexina/metabolismo , Pollos , Factores de Crecimiento de Fibroblastos/antagonistas & inhibidores , Factores de Crecimiento de Fibroblastos/metabolismo , Células HEK293 , Humanos , Placa Neural/embriología , Placa Neural/metabolismo , Transducción de Señal , Solubilidad
2.
Glycobiology ; 23(2): 169-77, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23028202

RESUMEN

Breast-fed infant microbiota is typically rich in bifidobacteria. Herein, major human milk oligosaccharides (HMOS) are assessed for their ability to promote the growth of bifidobacteria and to acidify their environment, key features of prebiotics. During in vitro anaerobic fermentation of infant microbiota, supplementation by HMOS significantly decreased the pH even greater than supplementation by fructooligosaccharide (FOS), a prebiotic positive control. HMOS elevated lactate concentrations, increased the proportion of Bifidobacterium spp. in culture, and through their fermentation into organic acids, decreased the proportion of Escherichia and Clostridium perfringens. Three principal components of HMOS, 2'-fucosyllactose, lactodifucotetraose and 3-fucosyllactose, were consumed in these cultures. These three principal oligosaccharides of human milk were then individually tested as supplements for in vitro growth of four individual representative strains of infant gut microbes. Bifidobacterium longum JCM7007 and B. longum ATCC15697 efficiently consumed oligosaccharides and produced abundant lactate and short-chain fatty acids, resulting in significant pH reduction. The specificity of fermentation differed by microbe species and strain and by oligosaccharide structure. Escherichia coli K12 and C. perfringens did not utilize appreciable fucosylated oligosaccharides, and a typical mixture of organic acid fermentation products inhibited their growth. In summary, 2'-fucosyllactose, lactodifucotetraose, and 3-fucosyllactose, when cultured with B. longum JCM7007 and B. longum ATCC15697, exhibit key characteristics of a prebiotic in vitro. If these bifidobacteria are representative of pioneering or keystone species for human microbiota, fucosylated HMOS could strongly promote colonization and maintenance of a mutualist symbiotic microbiome. Thus, these simple glycans could mediate beneficial effects of human milk on infant health.


Asunto(s)
Bifidobacterium , Leche Humana , Oligosacáridos , Trisacáridos , Bifidobacterium/efectos de los fármacos , Bifidobacterium/crecimiento & desarrollo , Lactancia Materna , Femenino , Fermentación , Fucosa/química , Fucosa/metabolismo , Humanos , Recién Nacido , Ácido Láctico/biosíntesis , Metagenoma/efectos de los fármacos , Leche Humana/química , Leche Humana/microbiología , Oligosacáridos/química , Oligosacáridos/metabolismo , Oligosacáridos/farmacología , Trisacáridos/farmacología
3.
Neuron ; 45(3): 353-9, 2005 Feb 03.
Artículo en Inglés | MEDLINE | ID: mdl-15694322

RESUMEN

Myelin-associated inhibitory factors (MAIFs) are inhibitors of CNS axonal regeneration following injury. The Nogo receptor complex, composed of the Nogo-66 receptor 1 (NgR1), neurotrophin p75 receptor (p75), and LINGO-1, represses axon regeneration upon binding to these myelin components. The limited expression of p75 to certain types of neurons and its temporal expression during development prompted speculation that other receptors are involved in the NgR1 complex. Here, we show that an orphan receptor in the TNF family called TAJ, broadly expressed in postnatal and adult neurons, binds to NgR1 and can replace p75 in the p75/NgR1/LINGO-1 complex to activate RhoA in the presence of myelin inhibitors. In vitro exogenously added TAJ reversed neurite outgrowth caused by MAIFs. Neurons from Taj-deficient mice were more resistant to the suppressive action of the myelin inhibitors. Given the limited expression of p75, the discovery of TAJ function is an important step for understanding the regulation of axonal regeneration.


Asunto(s)
Inhibidores de Crecimiento/metabolismo , Proteínas de la Mielina/metabolismo , Vaina de Mielina/metabolismo , Regeneración Nerviosa/fisiología , Receptores de Superficie Celular/metabolismo , Receptores del Factor de Necrosis Tumoral/metabolismo , Animales , Axones/fisiología , Sitios de Unión/fisiología , Células CHO , Células COS , Diferenciación Celular/efectos de los fármacos , Diferenciación Celular/fisiología , Cricetinae , Proteínas Ligadas a GPI , Ligandos , Sustancias Macromoleculares/metabolismo , Proteínas de la Membrana , Ratones , Ratones Noqueados , Glicoproteína Asociada a Mielina/metabolismo , Proteínas del Tejido Nervioso , Neuritas/efectos de los fármacos , Neuritas/metabolismo , Receptor Nogo 1 , Receptor de Factor de Crecimiento Nervioso , Receptores de Factor de Crecimiento Nervioso/metabolismo , Receptores del Factor de Necrosis Tumoral/genética , Proteína de Unión al GTP rhoA/metabolismo
4.
Nat Neurosci ; 8(6): 745-51, 2005 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15895088

RESUMEN

The control of myelination by oligodendrocytes in the CNS is poorly understood. Here we show that LINGO-1 is an important negative regulator of this critical process. LINGO-1 is expressed in oligodendrocytes. Attenuation of its function by dominant-negative LINGO-1, LINGO-1 RNA-mediated interference (RNAi) or soluble human LINGO-1 (LINGO-1-Fc) leads to differentiation and increased myelination competence. Attenuation of LINGO-1 results in downregulation of RhoA activity, which has been implicated in oligodendrocyte differentiation. Conversely, overexpression of LINGO-1 leads to activation of RhoA and inhibition of oligodendrocyte differentiation and myelination. Treatment of oligodendrocyte and neuron cocultures with LINGO-1-Fc resulted in highly developed myelinated axons that have internodes and well-defined nodes of Ranvier. The contribution of LINGO-1 to myelination was verified in vivo through the analysis of LINGO-1 knockout mice. The ability to recapitulate CNS myelination in vitro using LINGO-1 antagonists and the in vivo effects seen in the LINGO-1 knockout indicate that LINGO-1 signaling may be critical for CNS myelination.


Asunto(s)
Sistema Nervioso Central/embriología , Regulación hacia Abajo/genética , Vaina de Mielina/metabolismo , Glicoproteína Asociada a Mielina/genética , Fibras Nerviosas Mielínicas/metabolismo , Oligodendroglía/metabolismo , Receptores de Superficie Celular/genética , Animales , Diferenciación Celular/efectos de los fármacos , Diferenciación Celular/genética , Células Cultivadas , Sistema Nervioso Central/crecimiento & desarrollo , Sistema Nervioso Central/metabolismo , Técnicas de Cocultivo , Regulación hacia Abajo/efectos de los fármacos , Regulación del Desarrollo de la Expresión Génica/efectos de los fármacos , Regulación del Desarrollo de la Expresión Génica/genética , Humanos , Proteínas de la Membrana , Ratones , Ratones Noqueados , Microscopía Electrónica de Transmisión , Vaina de Mielina/genética , Vaina de Mielina/ultraestructura , Glicoproteína Asociada a Mielina/antagonistas & inhibidores , Glicoproteína Asociada a Mielina/metabolismo , Fibras Nerviosas Mielínicas/efectos de los fármacos , Fibras Nerviosas Mielínicas/ultraestructura , Proteínas del Tejido Nervioso , Oligodendroglía/efectos de los fármacos , Oligodendroglía/ultraestructura , Proteínas Proto-Oncogénicas/genética , Proteínas Proto-Oncogénicas/metabolismo , Proteínas Proto-Oncogénicas c-fyn , Interferencia de ARN/efectos de los fármacos , Interferencia de ARN/fisiología , Nódulos de Ranvier/genética , Nódulos de Ranvier/metabolismo , Nódulos de Ranvier/ultraestructura , Ratas , Ratas Long-Evans , Receptores de Superficie Celular/antagonistas & inhibidores , Receptores de Superficie Celular/metabolismo , Transducción de Señal/efectos de los fármacos , Transducción de Señal/genética , Proteína de Unión al GTP rhoA/metabolismo , Familia-src Quinasas/genética , Familia-src Quinasas/metabolismo
5.
Nat Neurosci ; 7(3): 221-8, 2004 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-14966521

RESUMEN

Axon regeneration in the adult CNS is prevented by inhibitors in myelin. These inhibitors seem to modulate RhoA activity by binding to a receptor complex comprising a ligand-binding subunit (the Nogo-66 receptor NgR1) and a signal transducing subunit (the neurotrophin receptor p75). However, in reconstituted non-neuronal systems, NgR1 and p75 together are unable to activate RhoA, suggesting that additional components of the receptor may exist. Here we describe LINGO-1, a nervous system-specific transmembrane protein that binds NgR1 and p75 and that is an additional functional component of the NgR1/p75 signaling complex. In non-neuronal cells, coexpression of human NgR1, p75 and LINGO-1 conferred responsiveness to oligodendrocyte myelin glycoprotein, as measured by RhoA activation. A dominant-negative human LINGO-1 construct attenuated myelin inhibition in transfected primary neuronal cultures. This effect on neurons was mimicked using an exogenously added human LINGO-1-Fc fusion protein. Together these observations suggest that LINGO-1 has an important role in CNS biology.


Asunto(s)
Proteínas de la Membrana/metabolismo , Proteínas de la Mielina/metabolismo , Glicoproteína Asociada a Mielina/metabolismo , Regeneración Nerviosa/fisiología , Receptores de Superficie Celular/metabolismo , Receptores de Factor de Crecimiento Nervioso/metabolismo , Secuencia de Aminoácidos/genética , Animales , Animales Recién Nacidos , Astrocitos/metabolismo , Axones/metabolismo , Secuencia de Bases/genética , Células Cultivadas , ADN Complementario/análisis , ADN Complementario/genética , Feto , Proteínas Ligadas a GPI , Humanos , Sustancias Macromoleculares , Proteínas de la Membrana/genética , Proteínas de la Membrana/aislamiento & purificación , Datos de Secuencia Molecular , Mutación/genética , Vaina de Mielina/metabolismo , Glicoproteína Asociada a Mielina/genética , Glicoproteína Asociada a Mielina/aislamiento & purificación , Glicoproteína Mielina-Oligodendrócito , Proteínas del Tejido Nervioso , Receptor Nogo 1 , Estructura Terciaria de Proteína/genética , Ratas , Receptor de Factor de Crecimiento Nervioso , Receptores de Superficie Celular/genética , Receptores de Superficie Celular/aislamiento & purificación , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/metabolismo , Transducción de Señal/genética , Proteína de Unión al GTP rhoA/metabolismo
6.
J Mol Biol ; 326(2): 381-96, 2003 Feb 14.
Artículo en Inglés | MEDLINE | ID: mdl-12559908

RESUMEN

The tryptophan repeat motif of the human immunodeficiency virus type-1 (HIV-1) reverse transcriptase (RT) is comprised of a cluster of six tryptophan residues at codons 398, 401, 402, 406, 410 and 414 that are highly conserved amongst primate lentiviral RTs. To determine the contributions of each of these residues for HIV-1 RT dimerization, we introduced changes into cloned DNA and tested the mutant subunits for their capacity to mediate heterodimerization in the yeast two-hybrid system. Changes of residue 401 to either leucine or alanine (but not phenylalanine) and residue 414 to leucine resulted in major reductions in beta-galactosidase activity produced from the reporter gene as compared to yeast expressing wild-type p66 bait and p51 prey fusions. Subunit selective mutagenesis revealed that the effect of these mutations was mediated mainly through the p66 subunit. Introduction of tryptophan mutants into the bacterial expression vector pRT6H/NB-PROT showed that RTs containing W401A or W401L substitutions (but not W401F) and W414L were defective for dimerization in vitro. Consistent with their dimerization defect, the W401A, W401L and W414L mutants were devoid of RT activity. Using the yeast two-hybrid system, we identified several second-site suppressors in p66 that restored interaction of the p66W401A bait to the p51W401A prey. The suppressors (T409I, D110G, V372A and I393M) also restored heterodimerization of bacterially expressed W401A subunits. When introduced into the W401A mutant, T409I was able to restore RT activity to 50% of the wild-type level. Examination of the RT structures revealed that K331 in p51 makes multiple hydrogen bond contacts with residues in the p66 loop spanned by W401 and W414. Consistent with this observation, the K331A RT mutant was dimerization-defective. We conclude that mutations at codons 401 and 414 in p66 impair dimerization by altering the proper positioning of structural elements in between these residues that make important contacts with p51.


Asunto(s)
Dominio Catalítico , Transcriptasa Inversa del VIH/química , VIH-1/enzimología , Subunidades de Proteína/metabolismo , Triptófano/química , Sitios de Unión , Catálisis , Cartilla de ADN/química , Dimerización , Escherichia coli/genética , Escherichia coli/metabolismo , Prueba de Complementación Genética , Glutatión Transferasa/metabolismo , Transcriptasa Inversa del VIH/genética , Transcriptasa Inversa del VIH/metabolismo , Histidina/química , Humanos , Enlace de Hidrógeno , Técnicas In Vitro , Lisina/química , Modelos Moleculares , Mutagénesis Sitio-Dirigida , Níquel/química , Reacción en Cadena de la Polimerasa , Subunidades de Proteína/química , Proteínas Recombinantes de Fusión/química , Saccharomyces cerevisiae/metabolismo , Triptófano/genética , Triptófano/metabolismo , Técnicas del Sistema de Dos Híbridos
9.
Mol Cell Neurosci ; 33(3): 311-20, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17011208

RESUMEN

LINGO-1 is a CNS-specific protein and a functional component of the NgR1/p75/LINGO-1 and NgR1/TAJ(TROY)/LINGO-1 signaling complexes that mediate inhibition of axonal outgrowth. These receptor complexes mediate the axonal growth inhibitory effects of Nogo, myelin-associated glycoprotein (MAG) and oligodendrocyte-myelin glycoprotein (OMgp) via RhoA activation. Soluble LINGO-1 (LINGO-1-Fc), which acts as an antagonist of these pathways by blocking LINGO-1 binding to NgR1, was administered to rats after dorsal or lateral hemisection of the spinal cord. LINGO-1-Fc treatment significantly improved functional recovery, promoted axonal sprouting and decreased RhoA activation and increased oligodendrocyte and neuronal survival after either rubrospinal or corticospinal tract transection. These experiments demonstrate an important role for LINGO-1 in modulating axonal outgrowth in vivo and that treatment with LINGO-1-Fc can significantly enhance recovery after spinal cord injury.


Asunto(s)
Axones/efectos de los fármacos , Proteínas de la Membrana/antagonistas & inhibidores , Proteínas del Tejido Nervioso/antagonistas & inhibidores , Proteínas Recombinantes de Fusión/uso terapéutico , Recuperación de la Función/efectos de los fármacos , Traumatismos de la Médula Espinal/tratamiento farmacológico , Análisis de Varianza , Animales , Apoptosis/efectos de los fármacos , Axones/fisiología , Caspasa 3/metabolismo , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Miembro Anterior/efectos de los fármacos , Humanos , Inmunohistoquímica/métodos , Etiquetado Corte-Fin in Situ/métodos , MAP Quinasa Quinasa 4/metabolismo , Proteínas de la Membrana/química , Proteínas de la Membrana/fisiología , Regeneración Nerviosa/efectos de los fármacos , Proteínas del Tejido Nervioso/química , Proteínas del Tejido Nervioso/fisiología , Organogénesis/efectos de los fármacos , Unión Proteica/efectos de los fármacos , Proteínas de Unión al ARN/metabolismo , Ratas , Ratas Sprague-Dawley , Traumatismos de la Médula Espinal/patología , Traumatismos de la Médula Espinal/fisiopatología , Factores de Tiempo , Tubulina (Proteína)/metabolismo , Proteína de Unión al GTP rhoA/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA